1. Home
  2. NMAD vs MAIA Comparison

NMAD vs MAIA Comparison

Compare NMAD & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Power Solutions Inc. Common Stock

NMAD

Nomad Power Solutions Inc. Common Stock

HOLD

Current Price

$2.40

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

SELL

Current Price

$1.10

Market Cap

69.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NMAD
MAIA
Founded
2020
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
69.2M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
NMAD
MAIA
Price
$2.40
$1.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $12.00
AVG Volume (30 Days)
260.9K
★ 439.4K
Earning Date
11-16-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
20.75
★ 33.33
EPS
N/A
★ N/A
Revenue
★ $200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$0.89
52 Week High
$6.40
$3.19

Technical Indicators

Market Signals
Indicator
NMAD
MAIA
Relative Strength Index (RSI) 32.30 48.45
Support Level N/A N/A
Resistance Level $4.35 $1.49
Average True Range (ATR) 0.49 0.10
MACD -0.13 0.02
Stochastic Oscillator 11.30 30.22

Price Performance

Historical Comparison
NMAD
MAIA

About NMAD Nomad Power Solutions Inc. Common Stock

Nomad Power Solutions Inc is a pioneering mobile, utility-grade truck-transportable battery energy storage system. The company's first-to-market products provide one megawatt of instantaneous power to an electrical grid or facility, bypassing months of construction typically required for traditional fixed installations. Its patented platforms, which are deployed on semi-trailers, serve emerging AI-driven applications, along with utilities, industrial operators, government agencies, and critical infrastructure providers through equipment sales, rentals and Energy-as-a-Service offerings. The group's products are Traveler, Voyager Eagle, Voyager Falcon, Voyager Hawk, and Compare Products. Its applications are Utilities, Peak Shaving, EV Charging, and Mining.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: